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1. Introduction
  Generalized anxiety disorders (GAD) is an anxiety 
disorders that is characterized by excessive, uncontrollable 
and often irrational worry about everyday things that is 
disproportionate to the actual source of worry. GAD is 
also a chronic and impairing disorder, independent of its 
comorbidity with other mental disorders[1]. It is a common 
neurosis. GAD patients at premorbid have a certain qualities 
and personalities, and it is related to psychosocial factors 
frequently. They constantly perceive threat, and show 
a preattentive bias to threat-related information. These 
excessive worries often interfere with daily functioning, 
as individuals suffering GAD typically anticipate disaster, 
and are overly concerned about everyday matters such 
as health issues, money, death, family problems, friend 
problems or work difficulties. Individuals often exhibit a 
variety of physical symptoms, including fatigue, fidgeting, 
headaches, nausea, numbness in hands and feet, muscle 
tension and aches, difficulty swallowing etc[2-6]. In addition, 
GAD patients typically score higher than normal people on 
a wide variety of interpersonal problems assessed by the 
Inventory of Interpersonal Problems[7]. At the same time, this 
worry prompted GAD patients keep up to seek for all things 
could be safety guarantee and smoothly. They have more 
requirements to the sense of determination. 
  Anxiety occurred when people perceive the threat or 
danger. Therefore, the pathogenesis of anxiety is considered 
be a psychogenic phenomenon. The occurrence of anxiety, 
Objective: To observe the clinical efficacy of Yiqiyangxin Chinese medicine compound combined 
with cognitive therapy on generalized anxiety disorders. Methods: A total of 202 generalized 
anxiety disorders patients were randomly allocated to a control condition (Paroxetine combined 
with cognitive therapy) or a treatment condition (Yiqiyangxin Chinese medicine compound 
combined with cognitive therapy). Subsequently, scores of Hamilton Anxiety Scale (HAMA), 
Zung Self-rating Anxiety Scale (SAS) and blood routine, urine routine, liver function, renal 
function, electrocardiogram were detected before treatment, 3 months, 6 months after treatment 
and 6 months after medicine withdrawal, respectively. Results: HAMA and SAS scores were 
significantly reduced in two groups (P<0.001) after treatment, but the differences in HAMA and 
SAS scores, apparent effect and effectiveness were not significant (P>0.05). HAMA and SAS scores 
were significantly increased in two groups (P<0.05) after medicine withdrawal, and there were 
significant differences in HAMA and SAS scores, recurrent disease and adverse reaction (P<0.001). 
The incidence of recurrent disease and adverse reaction in treatment group was low. Both two 
groups showed no apparent abnormality in blood routine, urine routine, liver and renal function, 
and electrocardiogram. Conclusions: Yiqiyangxin Chinese medicine compound combined 
with cognitive therapy can significantly reduce the recurrence after medicine withdrawal and is 
effective on generalized anxiety disorders. Furthermore, the incidence of adverse reactions is low. 
The treatment program is worthy clinic application in the further.
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development, maintenance and aggravation are closely 
related of their cognitive process. In this cognitive appraisal 
process, the brain alert system of excessive activation and 
the internal and external stimulus information as“excess 
dangerous” is considered to be the foundation of anxiety. 
Researchers considered that the individuals of high 
generalized anxiety have difficulties in transfering attention 
as emotional stimulate. Moreover, the uncertain situation 
will excitate the sense of uncertainty to GAD patients. In the 
end, it made GAD patients more easily in a nervous state. So 
the patients showed more sensitive to negative stimulate[8,9].
  Consequently, patients with anxiety disorders have always 
preferentially selected psychotherapy. However, in practice, 
we found that learn to master the psychotherapeutic 
technique have many difficulties. And, when we adopted 
the method, it must spend a lot of time during the treatment. 
Hence, at present, pharmaceutical treatment is still adopted 
for anxiety disorders in clinic[10,11]. Selective serotonin re-
uptake inhibitors (SSRIs) are a class of compounds typically 
used as antidepressants in the treatment of depression, 
anxiety disorders, and some personality disorders. 
Paroxetine is a SSRIs type of antidepressant drugs, because 
of its characteristics with excellent clinical efficacy and 
few side effects relatively, which are widely used in study 
and clinic[12]. However, after administration, once it takes 
effect, it must have a long-term maintenance treatment. 
As a rule, patients with anxiety disorders also need a long-
term maintenance treatment, but its efficacy remains to be 
further improved. In China, Chinese herbal medicine in the 
treatment of anxiety disorders is of a certain characteristics. 
It has been accepted for many patients now, but we still lack 
of large-scale, standardized, rigorous clinical controlled 
study.
  In this study, we compared the clinical efficacy between 
Yiqiyangxin Chinese medicine compound combined with 
cognitive therapy and paroxetine combined with cognitive 
therapy. 
2. Materials and methods
2.1. Participants and inclusion criteria
  In this study 202 GAD patients from outpatient department 
who were from East China Sanatorium between March, 2006 
and October, 2011 were selected. All participants consented 
to participate in this trial and were randomly assigned to 
treatment group (n=93) and control group (n=109). Patients 
in control group were treated by paroxetine combined with 
cognitive therapy, while patients in treatment group by 
Yiqiyangxin Chinese medicine compound combined with 
cognitive therapy.
  All patients were diagnosed according to DSM-桇
criteria[13], thus enhancing the probability of reasonably 
homogeneous samples. Measures included in this analysis 
were interview [typically the Hamilton Anxiety Scale 
(HAMA)] and self-report questionnaires [the Zung Self-
Rating of Anxiety (SAS)]. Entry criteria were as following: (a) 
HAMA total score >14, (b) excluded from the severe physical 
illness and severe personality disorder, and (c) patients 
and their families had informed consent. The general data 
compared with treatment group and control group as follows 
(Table 1), and there was no significantly differences (P>0.05) 
in gender, age, course of disease, etc.
 
2.2. Treatments
  In this study, GAD patients had cognitive therapy, and took 
different medicine according to different groups.  
  Patients in treatment group took Yiqiyangxin Chinese 
medicine compound, which can supplement Qi and 
nourish heart. It consists of 14 crude drugs: American 
ginseng 30 g, red ginseng 30 g, baical skullcap root 30 
g, cochinchnese asparagus root 30 g, dwarf lilyturf tuber 
30 g, Chinese magnoliavine fruit 30 g, danshen root 30 g, 
panax notoginseng 30 g, drug sweet flag rhizome 30 g, thin 
leaf milkwort root-bark 30 g, gardenia jasminoides 30 g, 
fermented soybean 30 g, amber 30 g, spina date seed 30 g.  
  The above listed drugs were ground into power, and were 
administrated to patients on an empty stomach with 10 g, 
two times daily. The course of treatment should last six 
months. Six months after medicine withdrawal, the condition 
was observed to decide if further steps should be taken. 
  Patients in control group took paroxetine hydrochloride 
tablets, which were provided by Sino-American Tianjin 
SmithKline Pharmaceutical Ltd. In this group, the course of 
treatment also lasted six months. Firstly, the dose as only 10 
mg, and was increased to 20 mg at the second week. And the 
dose may have changes at times according to the efficacy 
or side effects. But the limitation was at 20 to 60 mg a day. 
Furthermore, the minimum therapeutic dose should not be 
below 20 mg a day. During this treatment period, the mean 
dose was (24.9暲8.9) mg.
  Cognitive therapy is based on the theory that the disorder 
stems from constant perceptions of the world as dangerous 
place, resulting in a process of maladaptive and habitual 
interactions among cognitive, behavioral and physiological 
responses[14]. Consequently, cognitive therapy included 
identifying and labeling irrational thoughts and replacing 
them with positive self-statements or modifying them 
Table 1
Comparison of background variables.
Groups Gender Age (years) Educational degree Marital status COD(m)
Male Female SHSOL JCOH Unmarried Married
Control group 49 60 36.7暲12.9 62 47 51 58 34.6暲11.9
Treatment group 44 49 38.0暲13.1 57 36 39 54 33.9暲12.7
SHSOL: Senior high school or lower; JCOH: Junior college or higher; COD: Course of disease.
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by challenging their veracity. The cognitive modification 
approaches are often combined with behavioral treatments 
such as exposure or relaxation training. The behavioral 
components are viewed either as important in their own right 
or as a vehicle for practicing cognitive techniques[15].
  Hence, during this phase, firstly, each patient’s present 
information including theirs feeling, thinking mode and 
response were collected. This will help understand a wide 
range of the interactions factors, such as growth experience, 
core beliefs in cognition, error coping mode (avoidance), and 
variety reactions of patients with automatic processing mode 
(thinking, emotion and behavior). Secondly, we tried to find 
out thinking mode which leads to patients’ bad emotion and 
behavior. This will help them understand the relationship 
between cognition and psychological problems further. 
Together with patients, we discussed which mode would be 
the most perfect for us to understand the world, future and 
himself. And then, we made therapeutic targets together 
to find out the mode of thinking, belief and coping conflict 
with reality life. The cognitive therapy process carried out 
every half a month, each time lasted about 1 hour. Within 6 
months, GAD patients should receive 12 times therapy.
2.3. Clinical evaluation
  The efficacy was assessed by HAMA and SAS before 
the treatment, at the end of 3 months, 6 months (during 
treatment) and at the end of 6 months after medicine 
withdrawal. At every period, the evaluation was taken for 1 
time. When the treatment was over, the efficacy evaluation 
according to HAMA reduction rates was assessed by four 
criteria. After treatment compared with that before treatment, 
reduction rate曒75% was considered as clinical recovery, 
rate between 50%-70% as apparent effect, between 25%-
49% as effectiveness rate 敿25% as ineffectiveness. The total 
effective rate = (recovery + apparent effect + effectiveness ) / 
total number of cases 暳100%.
2.4. Laboratory examination
  In this study, the laboratory examination consisted of 
blood routine, urine routine, liver and renal function, and 
electrocardiogram. All items were measured 1 time before 
the treatment, at the end of 3 months, 6 months (during 
treatment) and at the end of 6 months after medicine 
withdrawal, respectively.
2.5. Statistical analysis
  The difference between treatment and control group were 
compared using three analysis ways of the calculation of 
descriptive statistics, t-test and 氈
2-test. Statistical analysis 
was done using SPSS version 19 software. 
3. Results
3.1.  HAMA scores
  As shown in Table 2, after treatment for 3 months and 6 
months, both control group and treatment group showed a 
very significantly decreases in HAMA score (Control group 
t=16.280, 16.504, both P<0.001; treatment group t=15.707, 
16.764, both P<0.001). However, there was no significantly 
difference between groups (P<0.05). But 6 months after 
medicine withdrawal there was significantly decrease in 
HAMA, SAS score in two groups compared with those during 
medicine taking (Control group t=9.229, P<0.001; treatment 
group t=2.223, P<0.001), and the score was significantly 
higher in control group than treatment group (t=6.699, 
P<0.05).
3.2. SAS scores
  As shown in Table 3, after treatment for 3 months and 6 
months, both control group and treatment group showed a 
very significantly decreases in SAS scores (Control group 
t=31.052, 31.155, both P<0.001; treatment group t=32.030, 
33.137, both P<0.001). However, there was no significantly 
difference between groups (P敿0.05). But 6 months after 
medicine withdrawal there was significantly decrease in 
HAMA, SAS score in two groups compared with those during 
medicine taking (Control group t=13.002, P<0.001; treatment 
group t=2.778, P<0.001), and the score was significantly 
higher in control group than treatment group (t=9.714, 
P<0.05). 
3.3.  Comparison of clinical efficacy 
  After treatment for 6 months, 30 cases in the control 
Table 2
HAMA scores (mean暲SD).
Group Before treatment 3 months after treatment 6 months after treatment 6 moths after medicine withdrawal
Control group 28.3暲8.6 11.3暲6.7 10.1暲6.8 19.3暲7.9
Treatment group 27.9暲8.4 10.7暲6.4   9.4暲6.5 13.6暲7.5
Table 3
 SAS scores (mean暲SD).
Group Before treatment   3 months after treatment 6 months after treatment 6 moths after medicine withdrawal
Control group 65.8暲9.4 30.4暲7.3 30.1暲7.4 45.8暲8.4
Treatment group 66.3暲8.9 29.1暲6.8 28.9暲6.9 35.8暲7.8
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group were in recovery, 37 cases had apparent effect 
(33.9%), 17 cases showed effectiveness, and 23 cases were 
ineffectiveness. The total effective rate (recovery + apparent 
effect + effectiveness) was 78.9%. In contrast, in the treatment 
group, 21 cases were in recovery, 35 cases had apparent 
effect (37.6%), 20 cases showed effectiveness, 17 cases were 
ineffectiveness. The total effective rate was 81.7%. 
  There was no significantly differences in apparent effect 
rate and effectiveness rate (氈
2=2.575, P> 0.05).
3.4. Recurrence rate and adverse reaction incidence 
  After medicine withdrawal, we found that there were 26 
cases with recurrence in the control group, including 7 
cases in recovery, 10 cases with apparent effect, and 9 cases 
with effectiveness. However, only 8 cases with recurrence 
were reported in the treatment group, including 2 cases 
in recovery, 3 cases with apparent effect, and 3 cases 
with effectiveness. There was a significantly difference in 
recurrence rate between two groups (氈
2=9.632, P<0.001).
  Laboratory examination showed that in the treatment group, 
10 cases had nausea, 3 cases had short-term diarrhea, and 
2 cases had dizziness. But after a while, these symptoms 
gradually disappeared. In the control group, 11 cases had 
dry mouth, 10 cases had dizziness, 4 cases had insomnia, 
and 9 cases had nausea. The adverse reaction incidence was 
significantly lower in control group (氈
2=11.840, P<0.001).
4. Discussion
  The cause of the anxiety disorder is not very clearly at 
present. GAD as the most common anxiety disorder has a 
high prevalence rate (3.6% to 5.1% lifetime and 3.1% 1-year 
prevalence)[15]. The current study considered that the cause 
is relevant to psychological, physical, biochemical and 
genetic factors. Previous studies found that patients with 
anxiety disorders could had increase in the content of lactate 
in blood. Similarity, it could lead to the 毬 adrenaline 
hyperactivity syndrome or induced locus ceruleus in 
noradrenergic neurons impulse increased, which could 
cause anxiety attacked. Moreover, animal experiments found 
that when electrical stimulated the locus ceruleus it also 
could cause anxiety reaction[10]. 
  In cognitive therapy, a variety of approaches have been 
used to treat GAD patients, such as Ellis’ rational-emotive, 
Meichenbaum’s self-instructional training, Beck and 
Emery’s model of cognitive therapy. The basic idea is that 
cognitive process is the mediate of behavior and emotion. 
Patients’ maladaptive behavior and emotion is relevant 
to the maladaptive cognitive. Because of this, during the 
treatment, we emphasized on changing the cognitive process 
and conception to correct the patients’ bad mood and 
behavior. Furthermore, treatment is especially emphasized 
on patients’ error cognition, not just aimed to theirs 
abnormal emotion and behavior[16-22]. The treatment target 
is to improve patients’ clinical symptoms by helping solve 
resource of error cognition, then to change theirs irrational 
beliefs and reconstruct theirs thinking mode and outlook on 
life. Cognitive therapy may be superior to paroxitine because 
it results in less relapse and recurrence and does not 
have risks of pharmacotherapy. In recent years, cognitive 
therapy in the treatment of anxiety disorder attract a lot of 
attention[21].
  During the treatment, as a rule, if drug therapy and non-
drug therapy show the same effect the non-drug treatment 
is preferred. However, in practice, there are many difficults 
in applying psychotherapeutic technique. Hence, at present, 
the drug therapy is still of widespread application. 
  Paroxetine (Parotine) is SSRIs and a selective inhibition of 
presynaptic membrane 5-HT reuptake pumps. However, 
its effect on the other kinds of neurotransmitters including 
acetylcholine, adrenaline, noradrenaline, histamine 
receptors is very little[11,12]. Because of its characteristic, 
it is used in treating anxiety disorders, with little adverse 
reaction and high safety. It is the first-line drug at present. 
However, it also causes some adverse reactions such as 
fatigue, constipation, diarrhea, dizziness, headache, dry 
mouth, and hidrosis symptoms. And many patients refuse to 
take this medicine.  
  “Anxiety disorders”is a emotional and psychogenic 
disorder. It belongs to depression, panic, fear, fright 
palpitation, heart palpitations, fearful throbbing, insomnia, 
hysteria, and lily disease in Chinese traditional medicine 
theory. Recently, it is reported many Chinese herbs 
which can relieve heat, strengthen the spleen and tonify 
blood, clear away the heat-evil and phlegm, promote the 
circulation of blood to remove blood stasis are used to treat 
this disease[23-25]. It is proposed that the pathogenesis of 
anxiety disorders is mainly relevant to deficiency of heart 
qi , and its dysfunction in moistening and nourishing, 
and in clearing orifices. This function is very important in 
regulating our body and mind.  
  It is stated in “Magic Pivot” that heart stores the spirit 
and governs the blood vessels. It is named “the office of 
the monarch” in “Plain Questions: Treatise of the Arcane 
Book of the Orchid Chamber of the Spirit Tower”. Sad 
and melancholy emotion has negative effect on the body. 
Deficiency of heart qi will lead to abnormal consciousness. 
Yiqiyangxin Chinese medicine compound consists of 14 
Chinese medicines. Ginseng, sweet, slightly warm, and 
can invigorate primodial qi to tranquilize and enhance 
intelligence[26]. Monomer ginsenoside is a central nerve 
sedative, and can calm the mind[26]. American ginseng, 
bitter, slightly sweet, cold, with meridian tropism to 
the heart, lung and kidney, and can supplement qi and 
promote fluid production. Saponin of American ginseng has 
significant anti-fatigue effect. Baical skullcap root, sweet, 
slightly warm, and is good at qi supplement[26]. Combination 
of cochinchnese asparagus root with dwarf lilyturf tuber can 
nourish yin and clear the heart[27]. Chinese magnoliavine 
fruit, sour, warm, can nourish the heart and yin to 
tranquilize. Pharmacological studies proved that Chinese 
magnoliavine fruit has effect on excitatory and inhibitory 
processes on cerebral cortex, and can balance both 
processes[26]. Pulse-Engendering Beverage, consisting of 
ginseng, dwarf lilyturf tuber and Chinese magnoliavine can 
invigorate qi and nourish the heart. Danshen root combines 
with panax notoginseng can promote the circulation of 
blood, remove blood stasis to promote tissue regeneration, 
and can nourish the heart to tranquillize. Drug sweet flag 
rhizome combined with thinleaf milkwort root-bark can 
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tonify the kidney, strengthen the brain, enhance intelligence 
and calm the mind[26]. Gardenia and Fermented Soybean 
Decoction including gardenia jasminoides and fermented 
soybean is also a famous for clearing away the heart-fire 
and eliminating vexation[27,28]. Amber also has the effect of 
tranquilizing and caliming the mind. Spina date seed, sweet, 
plain, not only can nourish the heart and tonify the liver but 
also strengthen the body, and calm the mind[29]. It is used 
to treat dysphoria and insomnia ued to blood deficiency. 
Moreover, pharmacological experiments also proved that 
with jujuboside as active constituents, spina date seed has 
significant effect of tranquilizing and inducing sleep[26]. 
  In this study, we use Yiqiyangxin Chinese medicine 
compound combined with cognitive therapy to treat 
GAD, which can invigorate the qi, nourish the heart, and 
tranquilize the mind. The result shows GAD patients are 
under control to a great extent in clinic. However, this study 
is lack of large-scale and multicenter clinical verification. 
Moreover, the oral dosage is high and the administration 
process is inconvenient. Thus, further studies are needed 
to find a way to change the dosage form, or find effective 
monomer or complex instead.
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